DSM FIRMENICH AG
Identification
Listing sponsor / Agent
ABN AMRO Bank N.V.
Symbol
DSFIR
ISIN code
CH1216478797
Code LEI
506700G44V67MPM4BI12
Exchange / Market
Euronext
Trading location
Amsterdam
Capitalization compartment
Compartment A
ICB
45102020 Food Products
Website address
https://www.creator-innovator.com/
Operation
IPO date
Di. 18/04/2023
IPO type
Direct listing
Company profile
DSM-Firmenich AG is a leading innovator in nutrition, health, and beauty. It reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With a comprehensive range of natural and renewable ingredients and renowned science and technology capabilities, the company uniquely works to create what is essential for life, desirable for consumers, and more sustainable for the planet.
Source:
Cofisem
-
Last Update:
03 Mar 2025
Key Executives
| Chief Executive Officer | Dimitri de Vreeze | ||||
| Chief Financial Officer | Ralf Schmeitz | ||||
| Director Research & Development | Sarah Reisinger | ||||
| Chief Risk Officer | Jane Sinclair | ||||
| General Counsel | Jane Sinclair | ||||
| Chief Human Resources Officer | Mieke Van de Capelle | ||||
| Source: Cofisem - Last Update: 03 Mar 2025 | |||||
Key figures
| Millenium | 2024 | 2023 | |||
|---|---|---|---|---|---|
| Net sales | 12.799 | 10.627 | |||
| Income from ordinary activities | 12.799 | 10.627 | |||
| Operating income | 561 | -497 | |||
| Cost of financial indebtedness net | 107 | 55 | |||
| Equity-accounted companies contribution to income | 0 | -7 | |||
| Net profit from discontinued activities | 0 | 2.789 | |||
| Net income | 280 | 2.153 | |||
| Net income (Group share) | 250 | 2.131 | |||
| Fiscal year end | 2024-12-31 | 2023-12-31 | |||
| Length of fiscal year (month) | 12 | 12 | |||
| Currency & Unit | EUR - millions | EUR - millions | |||
| Account Standards | IFRS | IFRS | |||
| Source: Cofisem - Last Update: 03 Mar 2025 | |||||